Portfolio company
ChamberTech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a hybrid ablation catheter system to treat patients with persistent atrial fibrillation by targeting both endocardial and epicardial heart surfaces.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Argá Medtech
This company develops non-thermal cardiac ablation systems and proprietary catheters for healthcare providers to treat atrial fibrillation and other cardiac arrhythmias.
MedLumics
This deep-tech company develops optically-guided ablation catheter systems used by cardiologists to treat atrial fibrillation through real-time tissue imaging and monitoring.
Affera
This medical technology company develops integrated cardiac mapping and ablation systems for electrophysiologists to treat patients suffering from heart rhythm disorders.
S4 Medical
This company develops an esophageal deviation device to protect patients from thermal injury during cardiac ablation procedures for atrial fibrillation.
Append Medical
The company develops a transcatheter system for left atrial appendage elimination to prevent strokes in patients with atrial fibrillation without leaving permanent metal implants.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
Epix Therapeutics
This company develops temperature-controlled cardiac ablation systems for clinicians to treat patients suffering from heart rhythm disorders such as atrial fibrillation.
Chamber
Chamber develops a platform that integrates clinical signals and workflows for cardiologists, patients and payers to support value-based cardiovascular care coordination.
